MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-WB-07-0021414
Hattis Pharmaceuticals Private Limited - pharma in Hooghly, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹63.56 Lakh
▲ 18% YoY
Net profit · FY 2025
₹69,609
Net margin 1.1%
EBITDA · FY 2025
₹2.51 Lakh
EBITDA margin 3.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹2.5 Lakh
Issued & subscribed
Open charges
₹10 Lakh
Secured borrowings
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
About Hattis Pharmaceuticals Private Limited
Data last updated:
Hattis Pharmaceuticals Private Limited is a private limited company based in Hooghly, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24299WB2018PTC227848. Its GSTIN is 19AAECH6485P1ZO (West Bengal).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2.5 Lakh. It is led by directors Avishek Hati and Sarbari Hati.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O. – Bidhan Chandra Hati Banamalipur P.O Keshabpur, Hooghly, West Bengal, India – 712413.
As per the financials filed for FY 2025, the company reported a revenue of ₹63.56 Lakh, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹69,609 (net margin 1.1%) and EBITDA of ₹2.51 Lakh (EBITDA margin 3.9%). Revenue has grown at a compounded annual rate (CAGR) of 30% over three years and 59% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
Hattis Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-07-0021414). For more details, the company can be reached via its website hattispharma.com.
Company details
CIN U24299WB2018PTC227848
Registration Number 227848
Incorporation Date 18 September 2018
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-WB-07-0021414
Key People
Avishek Hati Director Sarbari Hati Director Recognitions & Rankings of Hattis Pharmaceuticals
Contact details
Hattis Pharmaceuticals Private Limited's registered office is in Hooghly, West Bengal. Its website is hattispharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressC/O. – Bidhan Chandra Hati Banamalipur P.O Keshabpur, Hooghly, West Bengal, India – 712413
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Hattis Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Hattis Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Hattis Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Hattis Pharmaceuticals Private Limited, buy the company report.
Financials of Hattis Pharmaceuticals Private Limited
FY 2025 filings availableHattis Pharmaceuticals Private Limited reported revenue of ₹63.56 Lakh (up 18% YoY) for FY 2025.
Revenue · FY 2025
₹63.56 Lakh ▲ 18%
Net profit · FY 2025
₹69,609 margin 1.1%
EBITDA · FY 2025
₹2.51 Lakh margin 3.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 18%
3 years · compounded
▲ 30%
5 years · compounded
▲ 59%
EBITDA CAGR growth
1 year
▲ 28%
3 years · compounded
▲ 110%
5 years · compounded
▲ 60%
Revenue has grown at a compounded annual rate (CAGR) of 59% over five years, including 18% growth in the latest year. EBITDA rose 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.51 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹69,609 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.9% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hattis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Hattis Pharmaceuticals Private Limited
Hattis Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Avishek Hati | Director | 18 Sep 2018 | 8 Years 1 Months | Current |
| Sarbari Hati | Director | 18 Sep 2018 | 8 Years 1 Months | Current |
Auditor
Hattis Pharmaceuticals Private Limited is audited by ARUP KUMAR KUNDU for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ARUP KUMAR KUNDU | FY 2022 | 051372 |
Shareholding
The shareholding of Hattis Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Hattis Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹10 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Nov 2022 | 100653310 | Canara Bank | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Hattis Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hattis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Hattis Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAECH6485P1ZO | West Bengal | Active | 01 Dec 2018 |
To see the full GST registrations and return filing status of Hattis Pharmaceuticals Private Limited, buy the company report.
Recent activity
Hattis Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Avishek Hati was appointed as Director on 18 Sep 2018.
AGM
Hattis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Hattis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata Ii.
Charges
A charge with Canara Bank amounted to Rs. 10.00 Lakh with Charge ID 100653310 was registered on 19 Nov 2022.
Appointed
Avishek Hati was appointed as Director.
Appointed
Sarbari Hati was appointed as Director.
Incorporation
18 Sep 2018
Hattis Pharmaceuticals Private Limited was registered on 18 Sep 2018 with Roc Kolkata Ii & aged 8 years 1 month as per MCA records.
Frequently asked questions
Hattis Pharmaceuticals is an active private limited company based in Hooghly, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 September 2018 (8+ years old) and is registered under CIN U24299WB2018PTC227848.
Hattis Pharmaceuticals has 2 current directors:
- Avishek Hati - Director
- Sarbari Hati - Director
The latest financial statements of Hattis Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Hattis Pharmaceuticals is 19AAECH6485P1ZO, registered in West Bengal.
The CIN (Corporate Identification Number) of Hattis Pharmaceuticals is U24299WB2018PTC227848. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hattis Pharmaceuticals was incorporated on 18 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Kolkata.
Avishek Hati was appointed as Director on 18 Sep 2018. Sarbari Hati was appointed as Director on 18 Sep 2018.
Yes, Hattis Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-07-0021414).
Hattis Pharmaceuticals can be reached through the website hattispharma.com. Its registered office is in Hooghly, West Bengal, India.
The registered office of Hattis Pharmaceuticals is at CO. – Bidhan Chandra Hati Banamalipur P.O Keshabpur, Hooghly, West Bengal, India – 712413.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages